Patient-Derived Organoids for Chronic Pancreatitis Therapy
Researchers at the Salk Institute have developed a patient-derived organoid platform to study chronic pancreatitis, a condition affecting approximately three million people worldwide for which no cure currently exists. By generating 37 organoids from patients, the study—published in Cell Stem Cell—identified cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction as a key therapeutic target and uncovered … Read more